BioCentury
ARTICLE | Clinical News

Cevira: Final Phase IIb data

April 15, 2013 7:00 AM UTC

Final data from a double-blind, international Phase IIb trial in 262 patients with cervical intraepithelial neoplasia (CIN) 1/2 showed that 5% intravaginal Cevira improved the 6-month disease clearanc...